financetom
Business
financetom
/
Business
/
After RBI threatens regulatory action, Yes Bank says disclosure of nil divergence as per regulatory norms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
After RBI threatens regulatory action, Yes Bank says disclosure of nil divergence as per regulatory norms
Feb 19, 2019 2:48 PM

Private lender Yes Bank on Tuesday said the disclosure of 'nil divergence' was as per the regulatory guidelines, days after the RBI threatened to take action for making a confidential report public.

The bank was of the view that the information received under Risk Assessment Report (RAR) regarding "Divergence" was an Unpublished Price Sensitive Information (UPSI) and which is likely to be misused or leaked, Yes Bank said in a clarification to National Stock Exchange.

The exchange had sought clarification from the bank regarding Risk Assessment Report for the year ended March 31, 2018.

"It was deemed expedient to share this information through the stock exchanges to all market participants and not to withhold the same till finalisation of the Annual Results," it said.

Thus, it said, the bank has not indulged in any sort of misrepresentation or in providing any misleading information to the stock exchanges and the investors.

"The bank has not made any undue advantage or benefit by disseminating the UPSI. Hence, we humbly submit that the Bank has not misrepresented or mislead the stock exchanges/investors in terms of Regulation 4(1)(c) of Listing Regulations," it said.

Last week, RBI warned Yes Bank of regulatory action for disclosure of nil divergence report in violation of norms.

Yes Bank in a press release earlier last week had said the RBI has not found any divergence in the asset classification and provisioning done by the lender during 2017-18.

In a regulatory filing Friday, Yes Bank said it has received a letter from the RBI which noted that the Risk Assessment Report (RAR) was marked 'confidential' and it was expected that no part of the report be divulged except for the information in the form and manner of disclosure prescribed by regulations.

First Published:Feb 19, 2019 11:48 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Griffon's Q3 revenue misses expectations on weak consumer demand
Griffon's Q3 revenue misses expectations on weak consumer demand
Aug 6, 2025
Overview * Griffon fiscal Q3 revenue falls 5%, missing analyst expectations * Adjusted EPS for fiscal Q3 rises to $1.50, beating prior year * Co reports net loss due to Hunter Fan goodwill impairment Outlook * Griffon expects fiscal year 2025 revenue to be $2.5 bln * Company maintains adjusted EBITDA guidance of $575 mln to $600 mln * Griffon...
Brinks Q2 revenue up 4%, beats expectations
Brinks Q2 revenue up 4%, beats expectations
Aug 6, 2025
Overview * Brinks Q2 revenue rises 4% yr/yr, beating analyst expectations, per LSEG data * Adjusted EPS for Q2 beats consensus, driven by AMS/DRS revenue growth * Co repurchased $85 mln of common stock, reflecting strategic capital allocation Outlook * Brinks expects Q3 2025 revenue between $1,305 mln and $1,355 mln * Company sees full-year 2025 AMS/DRS organic revenue growth...
Top Premarket Decliners
Top Premarket Decliners
Aug 6, 2025
07:42 AM EDT, 08/06/2025 (MT Newswires) -- Evolus ( EOLS ) shares were 28% lower pre-bell Wednesday after the company reported late Tuesday a wider Q2 loss. LifeMD ( LFMD ) stock was down 27%, a day after the company lowered its full year 2025 revenue guidance. Personalis ( PSNL ) shares were 25% lower after the company reported late...
Copyright 2023-2026 - www.financetom.com All Rights Reserved